Haoran Wang

Dr. Haoran Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
HRHao Ren
Hao Ren
JLJiaqi Liu
Jiaqi Liu
YLYuqin Li
Yuqin Li
HWHaoran Wang
Haoran Wang
SGSizhan Ge
Sizhan Ge
JWJinhui Wu
Jinhui Wu

1 January 2018 in Theranostics
Verified
Journal Article
Open access
ZZZaigang Zhou
Zaigang Zhou
BZBaoli Zhang
Baoli Zhang
HWHaoran Wang
Haoran Wang
AYAhu Yuan
Ahu Yuan
YHYiqiao Hu
Yiqiao Hu
JWJinhui Wu
Jinhui Wu
Tumors are usually hypoxic, which limits the efficacy of current tumor therapies, especially radiotherapy in which oxygen is essential to promote radiation-induced cell damage. Herein, by taking advantage of the ability of perfluorocarbon (PFC) to promote red blood cell penetration, we developed a simple but effective two-stage oxygen delivery strategy to modulate the hypoxic tumor microenvironment using PFC nanoparticles.

1 February 2021 in Biomaterials
Verified
Journal Article
Closed access
HWHaoran Wang
Haoran Wang
YGYunfei Guo
Yunfei Guo
CWChao Wang
Chao Wang
XJXing Jiang
Xing Jiang
HLHonghui Liu
Honghui Liu
JWJinhui Wu
Jinhui Wu

5 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
WWWenguang Wang
Wenguang Wang
YCYuhao Cheng
Yuhao Cheng
PYPeng Yu
Peng Yu
HWHaoran Wang
Haoran Wang
YZYue Zhang
Yue Zhang
JWJinhui Wu
Jinhui Wu
Hypoxia-based agents (HBAs), such as anaerobic bacteria and bioreductive prodrugs, require both a permeable and hypoxic intratumoural environment to be fully effective. To solve this problem, herein, we report that perfluorocarbon nanoparticles (PNPs) can be used to create a long-lasting, penetrable and hypoxic tumour microenvironment for ensuring both the delivery and activation of subsequently administered HBAs. In addition to the increased permeability and enhanced hypoxia caused by the PNPs, the PNPs can be retained to further achieve the long-term inhibition of intratumoural O2reperfusion while enhancing HBA accumulation for over 24 h. Therefore, perfluorocarbon materials may have great potential for reigniting clinical research on hypoxia-based drugs.

14 February 2024 in Advanced Science
Verified
Journal Article
Open access
HWHaoran Wang
Haoran Wang
JMJiankang Mu
Jiankang Mu
YCYexing Chen
Yexing Chen
YLYali Liu
Yali Liu
XLXianghui Li
Xianghui Li
PCPeng Cao
Peng Cao
Personalized cancer vaccines based on resected tumors from patients is promising to address tumor heterogeneity to inhibit tumor recurrence or metastasis. However, it remains challenge to elicit immune activation due to the weak immunogenicity of autologous tumor antigens. Here, a hybrid membrane cancer vaccine is successfully constructed by membrane fusion to enhance adaptive immune response and amplify personalized immunotherapy, which formed a codelivery system for autologous tumor antigens and immune adjuvants. Briefly, the functional hybrid vesicles (HM‐NPs) are formed by hybridizing ginseng‐derived extracellular vesicles‐like particles (G‐EVLPs) with the membrane originated from the resected autologous tumors. The introduction of G‐EVLPs can enhance the phagocytosis of autologous tumor antigens by dendritic cells (DCs) and facilitate DCs maturation through TLR4, ultimately activating tumor‐specific cytotoxic T lymphocytes (CTLs). HM‐NPs can indeed strengthen specific immune responses to suppress tumors recurrence and metastasis including subcutaneous tumors and orthotopic tumors. Furthermore, a long‐term immune protection can be obtained after vaccinating with HM‐NPs, and prolonging the survival of animals. Overall, this personalized hybrid autologous tumor vaccine based on G‐EVLPs provides the possibility of mitigating tumor recurrence and metastasis after surgery while maintaining good biocompatibility.

9 February 2023 in Biomaterials Research
Verified
Journal Article
Open access
PDF file
WZWenwu Zhu
Wenwu Zhu
QWQingjie Wang
Qingjie Wang
JZJian Zhang
Jian Zhang
LSLing Sun
Ling Sun
XHXiu Hong
Xiu Hong
BHBing Han
Bing Han
Aims: Exosomes are known as nanovesicles that are naturally secreted, playing an essential role in stem-mediated cardioprotection. This study mainly focused on investigating if exosomes derived from miR-214 overexpressing mesenchymal stem cells (MSCs) show more valid cardioprotective ability in a rat model of acute myocardial infarction (AMI) and its potential mechanisms. Methods: Exosomes were isolated from control MSCs (Ctrl-Exo) and miR-214 overexpressing MSCs (miR-214 OE -Exo) and then they were delivered to cardiomyocytes and endothelial cells in vitro under hypoxia and serum deprivation (H/SD) condition or in vivo in an acutely infarcted Sprague-Dawley rat heart. Regulated genes and signal pathways by miR-214 OE -Exo treatment were explored using western blot analysis and luciferase assay. Results in vitro: , miR-214 OE -Exo enhanced migration, tube-like formation in endothelial cells. In addition, miR-214 OE -Exo ameliorated the survival of cardiomyocytes under H/SD. In the rat AMI model, compared to Ctrl-Exo, miR-214 OE -Exo reduced myocardial apoptosis, and therefore reduced infarct size and improved cardiac function. Besides, miR-214 OE -Exo accelerated angiogenesis in peri-infarct region. Mechanistically, we identified that exosomal miR-214-3p promoted cardiac repair via targeting PTEN and activating p-AKT signal pathway. Conclusion: Exosomes derived from miR-214 overexpressing MSCs have greatly strengthened the therapeutic efficacy for treatment of AMI by promoting cardiomyocyte survival and endothelial cell function. Graphical